Initiating breastfeeding within the first hour of life confers an important benefit in terms of child mortality and severe morbidity. Intestinal permeability to ingested macromolecules and immunoglobulins is limited to the first days of human life. These exchanges cease in the very early post-partum period but may increase beyond the neonatal period in response to local inflammation or introduction of a weaning food. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
| INTRODUCTION
The nutritional and immunologic benefits of human milk consumption through exclusive breastfeeding (EBF) on child health, development, and survival have led to the universal recommendation of EBF as the "gold standard" for early infant feeding worldwide. 1 Breastfeeding is associated with a lower incidence of globally important infectious diseases like infectious diarrhea and pneumonia, as well as increasingly important chronic diseases such as diabetes. 2, 3 As a result of potential health impacts, it is estimated that up to 15 million child deaths could be averted in 10 years 4 An example of this mechanistic complexity underlies the recommendation to initiate breastfeeding within 1 hour of delivery. Evidence associated with this is that early initiation of breastfeeding is associated with a greater likelihood of EBF being practiced, and practiced for a longer duration. 6 These better EBF practices may in fact be due to a stronger maternal-infant bond that develops with the early maternalinfant skin-to-skin contact when breastfeeding occurs within 1 hour.
In a recent meta-analysis of almost 100 000 infants, initiation of breastfeeding within 1 hour and practice of EBF was independently associated with significantly lower neonatal and early infancy mortality. 6 While EBF practices according to current recommendations would ultimately contribute to a greater overall volume of breastmilk consumed over the EBF period, it may also be important that the timing of early initiation of the practice of breastfeeding also ensures that the infant has access to unique early benefits of breastmilk. It is well established that breastmilk composition varies throughout lactation stages, both nutritionally and immunologically. Of the human milk immune factors reported thus far, immunoglobulins (Ig) and immune cells are in greatest concentration in colostrum compared to mature milk. [7] [8] [9] During the first 2 weeks after birth, breastmilk leukocyte content decreases dramatically to reach a concentration that is thereafter maintained in mature milk throughout lactation. 10 While immunologic variation in milk composition during lactation has been studied on a limited basis, 11, 12 this has not yet been considered closely in conjunction with the timing of the infant intestinal development, both in terms of the structure and function of the infant mucosa and maturation of mucosal immunology. The human neonatal intestine is characterized by increased permeability to large molecules, including Ig and other macromolecules, 13 and breastfeeding is associated with earlier gut closure of intestinal permeability. 14 
| (RE)DEFINING NEONATAL GUT CLOSURE
The intestinal mucosa forms a physical, biochemical, and immune barrier that blocks or regulates the transfer of the gut luminal contents to the interstitial submucosal tissue. The neonatal intestinal mucosa barrier is distinct in many known ways from a healthy adult intestinal mucosal barrier. A significant difference from a barrier perspective is the greater, but temporary, permissiveness of the neonatal mucosa.
"Gut closure" closely relates to neonatal gut permeability which, in turn, is directly linked to two physiologic mechanisms.
The first mechanism is most classically associated with the concept of gut closure. It consists of the passage of macromolecules from the lumen of the infant's gut via paracellular space to blood. In the intestinal epithelium, the intercellular junctions are made up of at least three distinct elements: tight junctions, adherens junctions, and desmosomes. 15 The most apical structures, the tight junctions, are the rate-limiting factor in epithelial paracellular permeability. M cells are highly differentiated epithelial cells associated with Peyer's patches (PP) and tonsils. They have antigen transport functionalities that are interlocked with adjacent cells with similar intercellular junctions as enterocytes.
The intestinal permeability to macromolecules can be estimated in vivo by non-invasive methods. A common method is the lactulose/ mannitol test that assesses urinary excretion of orally ingested macromolecules. Lactulose permeates across the gut surface only in case of epithelial cell damage or intercellular junction defects, whereas mannitol, being threefold smaller in size, is readily absorbed through the normal gut epithelial barrier. These inert sugars are excreted in urine, after being filtered freely at the glomerulus level. Hence, an elevated lactulose/mannitol ratio in urine is a useful indirect indicator of gut permeability. In humans, intestinal permeability to macromolecules is very high shortly after birth and then drops dramatically within the first 7 days of life ( Figure 1 ). Interestingly, this period of increased permeability is longer in non-breastfed infants. 14 Breastmilk is a rich source of miRNA for the infant. 25 We have recently The duration of FcRn expression on the neonatal gastrointestinal tract varies between mammalian species and, for many, occurs at weaningbut, by contrast, much earlier in human infants. Rodents and many other mammals depend exclusively on this transport mechanism for prolonged periods to maintain adequate levels of IgG in blood. 13, 26, 27 For example, maternal immunity is mediated exclusively by colostral Ig in ruminants. 28 FcRn are present on the luminal surface of proximal small intestine enterocytes. FcRn-mediated uptake in rat pups
accounted for approximately 80% of serum IgG levels. 29 The presence of this receptor on the fetal enterocyte surface is responsible for in utero IgG transport from amniotic fluid to the fetal blood. 30 In human neonates, FcRn is expressed on the luminal surface of enterocyte for a very short period, only a few hours or days after birth. In contrast,
FcRn persists for the whole life on the contra-luminal surface of those cells and contributes to the transport of Ig, including secretory IgA (SIgA), from the submucosae and blood to the mucosal surfaces. 31, 32 This receptor is also present on the surface of syncytiotrophoblastic cells where it ensures active transport of maternal IgG across the placenta to fetal blood. [33] [34] [35] [36] Glycosylation of maternal IgG evolves over gestational time and likely also during lactation. 37 Hyperglycosylated IgG has potent antiinflammatory properties. 38 It is therefore possible that breastmilk IgG transferred to the nursing infant contributes to the support of the antiinflammatory microenvironment at the neonatal gut surface and thus to the neonatal maturation and regulation of the immune response. While these mechanisms support the global benefits of breastfeeding, they do not fully explain why breastfeeding initiation within the first hour of life has such tremendous impact on the reduction in infant mortality. 6 We propose a third mechanism involving the im- During the first weeks of life, a uniquely hospitable infant intestinal environment exists for maternal cells in breastmilk to cross intact through the neonatal intestinal barrier. This is due to the presence of diminished digestive enzyme activity, infant stomach hypochlorhydria, and loose intestinal intercellular junctions (with access to paracellular space), together allowing for the transfer and survival of maternal milk cells. As an example, milk macrophages survive several hours in the gastrointestinal tract of infant mice after oral administration. 39 Cellular complexes produced during milk-saliva interactions may play a key role in protecting breastmilk cells from acidity during gastric transit. 40 To date, a comprehensive investigation to clearly identify which milk cell types transit intact through the stomach environment has not been conducted. However, early experiments performed more than 30 years ago clearly demonstrated an active uptake of living lymphocytes through the neonatal gastric mucosa. 41 In rodents and non-human primates with a prolonged period of gut permeability, nesting of breastmilk cells into pup's tissues has been largely demonstrated, either as a long-lived cell population 42 or as a transient homing in neonatal tissues. 43 The most likely mechanism of cell transfer involves paracellular passage of breastmilk cells by means of weakened interepithelial junctions. 44 Demonstration in humans is F I G U R E 2 Schematic overview of the mother to fetus/infant cellular exchanges at the placental and the intestinal levels. Passive and active processes are indicated, as well as the nature of the exchange hampered by the much shorter duration of gut permeability and an inability to obtain infant intestinal tissue samples in a non-invasive manner for research purposes.
Intriguingly, the first few weeks of human life is also a period of rapid maturation of the neonatal cellular immune response through the maturation of the Toll-like receptor (TLR) system, a phenomenon that is considerably enhanced by breastfeeding. 45 Again, the temporal association between increased gut permeability and the timing of the maturation of the infant TLR system suggests that the breastfed neonate may be using biologically active milk cells in an effective and developmentally appropriate way.
| THE NEONATAL INTESTINAL MUCOSAL IMMUNE SYSTEM: IN NEED OF MILKY HELP FROM MOM?
A common perspective is that humans are born with an incompetent and immature immune system. This view is in fact grossly exagger- 
| IMMUNOLOGIC COMPOSITION OF HUMAN MILK: DISTINCT FROM HUMAN BLOOD
The first milk that is excreted, colostrum, has highly concentrated ma- In humans, breastmilk lymphocytes consist mainly of an extralymphoid memory cell population. 61 The majority of CD4 and CD8 T cells are effector memory cells. 62, 63 The proportion of activated immune cells is also much higher in breastmilk than in blood. 64 The mammary gland is an effector site of the maternal mucosal im- 67 In the last few months, our group has been able to con- 
| BREASTMILK CELL TRAFFICKING COULD DRIVE NEONATAL IMMUNE SYSTEM MATURATION/REGULATION
Compelling evidence exists from many animal models that confirm an effector role of immune cell trafficking from the mammary gland to the infant's mucosal surfaces or tissues. Table 1 summarizes the major findings related to breastmilk cell trafficking in animals. With very few exceptions, 72 all experiments on animal models were conducted during the period of intense gut permeability suggesting that milk lymphocytes are not only taken up by the breastfed offspring but that this process results in a transfer of immunologic information and enhances the early immune response. 73 Interestingly, the experiments conducted in the study from Cabinian et al 74 antimaternal immunity and persist until adulthood. 42, 79 Indeed, MMC may explain the better acceptance of maternal transplants among individuals that were previously breastfed as infants. [79] [80] [81] [82] Microchimerism has also been implicated in tolerance in hematopoietic stem cell transplantation. 83 Compelling evidence also points to the likelihood that maternalfetal bidirectional cell exchange during pregnancy, and microchimeric seeding may promote the success of future pregnancies. 84 The fetus is exposed to genetically foreign NIMAs during in utero life, and it is hypothesized that this phenomenon can prime tolerogenic responses. breastfeeding-induced MMC can only increase these beneficial functions in the child in an additive or synergistic fashion (see Table 2 ). 87 Breastmilk cells seem to transfer immune regulatory and tolerance signals to the nursing infant as illustrated by renal allograft tolerance modulated by previous infant feeding practice and by the familial link to the donor. In a study performed in 55 recipients of maternal-donorrelated renal transplant, a history of breastfeeding was associated with a more favorable post-transplant course, as 82% of previously breastfed recipients remained free of rejection at 1 year post-transplant vs 57% in previously non-breastfed recipients. 88 Similar association was not carried out when the father was the organ donor. 88 However, in recipients of kidney from sibling donors, the graft outcome was also more favorable in previously breastfed recipients, suggesting that breastfeeding effect is not entirely specific for maternal antigens. 89 In renal transplantation from sibling donors who are mismatched with the recipient for HLA haplotype, graft survival is higher when the donor has maternal HLA antigens not inherited by the recipient than when the donor has paternal HLA antigens not inherited by the recipient. 90 This strongly suggests that exposure to NIMAs by breastfeeding-as the only conceivable source of exposure-may play a beneficial role in renal graft tolerance.
| CONCLUSIONS
As the gestational period transitions to the early neonatal period, the infant gut may be considered as a temporary, but important developmental extension of the role played by the placenta during intrauterine life. At the same time, breastmilk plays the role of maternal blood Recent meta-analysis from very large cohorts suggests that early initiation of breastfeeding immediately after birth confers an important benefit to the neonate by reducing severe morbidity and mortality. The traffic of maternal immune cells from breastmilk to the infant mucosal surfaces and tissues may be the explanatory mechanism associated with such benefit. This would provide further evidence in support of public health messages that reinforce the importance of breastfeeding.
While EBF for 6 months is the universal recommendation, for various reasons not all infants are fed this way. "Early and any" breastfeeding initiated in the maternity ward may be better than no breastfeeding at all, even if for any reason, the mother later chooses to feed her infant differently.
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